|
|
|||||||||
Dr. Simon is Assistant Clinical Professor of Obstetrics and Gynecology, St. Lukes-Roosevelt Hospital Center, University Hospital of Columbia University, College of Physicians and Surgeons, New York, NY.
Dr. Lee is Assistant Professor of Medicine, Brigham and Womens Hospital, Dana Farber Cancer Institute, Boston, MA.
Dr. Partridge is Instructor in Medicine, Brigham and Womens Hospital, Dana Farber Cancer Institute, Boston, MA.
Dr. Runowicz is Director, The Carole and Ray Neag Comprehensive Cancer Center; Northeast Utilities Chair in Experimental Oncology; Professor of Obstetrics and Gynecology, University of Connecticut School of Medicine, Farmington, CT.
In this review, the reproductive impact of treatments for several common cancers and options to maintain fertility in women and men undergoing treatment for these cancers will be discussed. The options available to any particular cancer survivor will depend on her or his age at the time of diagnosis and treatment, cancer type and primary site, stage, and type of treatment.
This article has been cited by other articles:
![]() |
A. A. Patel, S. Mini, R. P. Sutaria, M. B. Schoenhage, A. R. Patel, E. K. Radeke, and H. A. Zaren Reproductive Health Issues in Women With Cancer J. Oncol. Pract, March 1, 2008; 4(2): 101 - 105. [Full Text] [PDF] |
||||
![]() |
M. T. Knobf The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors. Oncologist, February 1, 2006; 11(2): 96 - 110. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |